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he purpose of this study was to evaluate the effect of the pool of bovine BMPs on the treatment of intrabony
defects. The sample comprised 15 patients aged 26 to 57 years old presenting with 10 pairs of lesions of 2 or 3
walls or 2-3 walls ³5mm, located in the same type teeth (premolar or molar) and same jaw. The test defects were treated
with combination of a pool of bovine bone morphogenetic and resorbable hydroxyapatite carrier (BMPs- HA),
bovine demineralized bone matrix (MB) and coverage by a bovine collagen barrier membrane. The control defects
were treated with MB-HA and covered by a bovine collagen membrane. The clinical measurements at six months
after therapy in the test group revealed a reduction in the mean probing pocket depth (PPD) of 1.63 ± 1.41mm (B) and
1.93 ± 0.96mm (L) and a mean change in the clinical attachment level (CAL) of 1.60 ± 1.16mm (B) and 1.46 ± 0.97mm
(L). The control group showed a mean reduction of PPD of 1.93 ± 1.34mm (B) and 2.0 ± 1.51mm (L) and a mean change
of CAL of 1.03 ± 1.24mm (B) and 1.30 ± 1.14 mm (L). The analysis of variance (ANOVA) demonstrated that the
changes in the clinical parameters were statistically significant (p<0.05). There were no significant differences
between the test and controls subjects (Student’s test, p<0.005). These findings suggest that the use of a pool of
bovine BMPs do not provide added effects to GTR in the treatment of intrabony defects.
UNITERMS: Periodontal regeneration; Intrabony defects; Bone morphogenetic proteins.
INTRODUCTION
According to the principle of Guided Tissue
Regeneration (GTR), use of the barrier membrane15 aims at
guiding and mechanically controlling the tissue regeneration
by preventing the adjacent epithelial and gingival connective
tissues from accessing the prepared root surfaces during
the healing process. This provides a selective re-population
of the root surface and surrounding spaces by the
periodontal ligament and alveolar bone cells. However, the
results are not totally predictable, even though preclinical
studies in animal models and clinical studies have
demonstrated the possibility of an effective increase in
periodontal regeneration by the GTR.
On the other hand, improvements in molecular and cellular
biology have been allowing a better comprehension of the
functions of the growth factors and their interaction with
the extracellular matrix and the cells during the healing
process. A new alternative to the treatment of bone defects
came from the findings of Urist27 and Reddi; Huggins17, who
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demonstrated that the devitalized and demineralized bone
matrix is able to induce heterotopic osteogenesis. The bone
morphogenetic proteins (BMPs), present in the interior of
bone matrix, display osteogenic and osteoinductive
properties that, when released, induce the sequential process
of formation of new bone tissue.
In addition, many microscopic studies have supported
the premise that the BMPs provide regeneration of the tooth
supporting apparatus, including the cementum, periodontal
ligament and alveolar bone 2,6, 9, 10,11,18,19,21,22.
The difficulty to obtain enough amounts of viable human
bone, associated with the costs and risks of transmission of
pathological entities, many studies have been applying
bovine bone matrix for the treatment of intrabony defects.
This utilization is based on the homology proved by cloning
of DNA of human BMPs with bovine bone. However, the
commercially-prepared demineralized bone powder
(DFDBA) presents an insufficient quantity of BMPs to
induce differentiation of mesenchymal cells in enough
numbers of osteoprogenitor cells to yield a clinically
significant bone neoformation1.
In this study, application of the pool of bovine BMPs
(GENPRO™- Baumer S.A.), developed from the lyophilized
bovine bone matrix, was evaluated. In a previous study, this
biomaterial demonstrated favorable results regarding the
structural biocompatibility, and induced bone regeneration
in perennial skull defects in Guinea pigs24 when associated
with the bone matrix.
The pool just contains the BMP extract, since the
proteins concentrate the osteogenic potential generically
attributed to the matrix. Compared to other biomaterials,
which use the whole matrix, this extract gathers greater
quantities as well as different types of those proteins and
therefore is named pool of BMPs.
This work associated application of the collagen
resorbable membrane Type I (GENDERME™- Baumer S.A.),
obtained from the bovine cortical bone7,23 and the pool of
bovine BMPs in the periodontal regenerative therapy, in an
attempt to evaluate the clinical results of the combination of
those regenerative modalities.
MATERIALS AND METHODS
Fifteen patients of both genders (aged 26 to 57 years old
with a mean age of 36.06 years) were selected at the
Periodontics clinic of Bauru Dental School, University of
Sao Paulo, SP, Brazil. The possible types of treatment,
associated risks and benefits were explained to the patients,
all of whom signed and informed consent form agreeing to
the treatment. The study design and the consent term were
approved by the Ethics Committee of Bauru Dental School.
The inclusion criteria comprised the following: 1) good
systemic health; 2) no use of drugs such as antibiotics,
corticoids, chemotherapeutics, or immunological modulators
that might alter the response of the oral tissue; 3) non-
smokers; 4) radiographic evidence of at least one pair of
interproximal intrabony defects with 2 or 3 or combined 2-3
walls located in the same jaw (maxilla or mandible) and the
same type of tooth (premolars or molars), without
involvement of the furcations; vital or root canal treated
teeth; attachment level ³5mm; tooth mobility < class II.
The exclusion criteria comprised patients with reported
allergy to bovine products, tetracycline, chlorhexidine,
history of anaphylactic reactions and state of pregnancy or
alcoholism.
After selection, all patients underwent the initial therapy
consisting of oral hygiene instruction, scaling and root
planning and necessary occlusal adjustment.
Reevaluation was performed six weeks after phase I
therapy to confirm the suitability for this periodontal surgery
study. The following clinical parameters were assessed at
the reevaluation and regarded as baseline values: Plaque
Index14, Gingival Index14, probing pocket depth (PPD),
gingival recession (GR) and clinical attachment level (CAL).
The measurements were made at 6 sites per tooth
(mesiobuccal, midbuccal, distobuccal, mesiolingual,
midlingual, and distolingual). The PPD and CAL were
repeated within a week with a millimeter periodontal probe
“Michigan 0” type with Willians (Hu-Friedy -USA) markings.
Individualized film holders were used for the achievement
of standardized radiographs.
At least six weeks after conclusion of the initial
periodontal therapy, the sample was submitted to the surgical
phase using the split-mouth design, on which 2 interproximal
sites were randomly assigned to the experimental or control
groups.
After extra and intraoral asepsis of the surgical field,
full-thickness mucoperiosteal flaps were raised by means of
buccal and lingual intracrevicular incisions until at least one
mesial and one distal adjacent teeth, followed by removal of
the granulation tissue and bone debridement with Goldman
Fox curettes #1, 2, 3 and 4 (HU-FRIEDY USA). After that, a
50% citric acid solution, pH 1.0 with 10% tetracycline solution
was applied over the root surface and bone defects for three
minutes, followed by rinsing with sterile saline solution for
one minute.
Subsequently, a pool of bone morphogenetic proteins
(GENPRO™, Baumer S.A) obtained from the bovine bone
matrix of bovine fetus with resorbable hydroxyapatite carrier
(HA) (BMP HA at 1:20 ratio), with addition of demineralized
lyophilized bovine bone matrix (MB) (MO-GEN-OX™,
Baumer S.A) at 1:1 ratio in sterile saline solution was applied
on the test defects. The mixture was condensed in the
defects and filled with little excess in order to provide support
to the barrier.
In the control sites there was application of MB with HA
(MB-HA), at 1:1 ratio, therefore excluding just the pool of
bovine BMPs.
After filling the defects with the respective biomaterials,
both the test and control sites were covered with a 160-mm
thick resorbable membrane obtained from bovine cortical
bone (GENDERME™, Baumer S.A). The bioresorbable
membrane was trimmed and adjusted over the whole defect
so that the entire defect and 3mm of alveolar bone were
completely covered. The flap was repositioned at the height
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of the cementoenamel junction, adapted over the membrane
and sutured with Vicryl 6.0 suture and 1.50 ½ J105 G
(ETHICON) needle.
The postoperative instructions included prescription of
100mg of oral doxycycline once a day for fourteen days and
rinsing with 0.12% chlorhexidine digluconate solution twice
a day for six weeks. In addition, the patients received
orientations on other postoperative cares, adequate use of
dental floss and delicate brushing of the operated area during
the first postoperative weeks.
At three and six months after surgery, new clinical
measurements were undertaken, and new standardized
radiographs were obtained at six months.
Analysis of the means of PPD and CAL was performed
by means of analysis of variance (ANOVA), at p<0.05, in
order to indicate differences between the initial, 3-month
and 6-month measurements of each group. Whenever
significant differences were found, the Tukey test was
applied to indicate in which periods the differences were
significant. The Student’s t test  (p<0.05) was applied to
indicate whether the variations in PPD and CAL in the initial,
3-month and 6-monthj periods presented statistically
significant differences between the test and control groups.
RESULTS
According to Table 3, the variation in the probing depth
on the B and L aspects, between the measurements at the
initial, 3-month and 6-month periods did not present
statistically significant differences between the test and
control groups.
According to Table 7, the variation in the clinical
attachment level in the measurements at the initial (MI), 3-
month (3m) and 6-month (6m) periods did not present
statistically significant differences between the test and
control groups.
In Table 8, the analysis of variance showed a significant
difference  (p<0.05) between the evaluation periods
regarding the mean CAL on the buccal and lingual aspects
of the test and control groups, respectively. The Tukey test
(Schedule 9) demonstrated significant differences in the
initial measurement compared to the 3-month and 6-month
periods.
DISCUSSION
Periodontal regeneration results in the formation of new
bone, new cementum and new periodontal ligament,5 and
many methods have been proposed to reach this aim. In the
present in vivo study, the effects of the utilization of a pool
of bovine BMPs associated with demineralized lyophilized
bovine bone matrix and bovine collagen membrane in the
treatment of periodontal human intrabony defects by means
of clinical parameters have been evaluated.
Even though studies on GTR have evidenced formation
of new attachment connective tissue, deposition of new
cementum, new periodontal ligament and new bone
formation in surgically created defects submitted to GTR
with resorbable membrane barriers15, some studies reported
the non-formation of new bone16 and detected dense
connective tissue instead of alveolar bone8 after application
of barriers in surgically created defects in animals. In those
situations, the clinical repair of bone defects cannot be
defined as regeneration, even when there is formation of
new attachment connective tissue. For that reason, formation
of new tissue with the same structural and functional
characteristics of the tissue existing before the destructive
disease is not observed 5.
The resorbable collagen membrane used in this study
was obtained from collagen of organic matrix Type I of bovine
cortical bone. Studies on animal models revealed good
tolerance of the tissues to this biomaterial and complete
resorption six months after its placement in orthotopic sites
in the surface of perennial skull defects in Guinea pigs23.
The association of resorbable membranes in different
regenerative modalities has been established in microscopic
and clinical studies, which observed different results
regarding the periodontal regeneration, improvement of the
clinical parameters and bone gains13.
Since the commercially-prepared demineralized bone
powders present bone matrix with insufficient quantity of
BMPs1, therefore not attaining a good regenerative response
in the treatment of bone defects, the addition of a pool of
BMPs to the bone matrix in this study aimed at assuring the
osteogenic activity and the further roles of those proteins
in periodontal regeneration. However, the data achieved
indicated that the addition of the pool of BMPs did not
yield better results.
The BMPs are considerably  involved in the healing of
surgical wounds, especially in periodontal regeneration,
since they initiate formation of new bone tissue by
stimulating the differentiation of undifferentiated
mesenchymal cells in osteoblasts28. The formation of new
bone in surgically created defects treated with BMPs has
been reported in a microscopic study6.
Microscopic studies have showed the formation of new
cementum, periodontal ligament and bone neoformation by
application of rhBMP-210,11,21,22 and other BMPs6,18,19.
Nevertheless, Choi et al.3 pointed out the non-significant
formation of cementum.
The clinical findings of this study demonstrated that the
BMPs employed did not being about additional benefits.
Similar results have been noticed between the test and
control sites regarding the gain of CAL and reduction in
PPD.
In the test sites, on which the pool of BMPs has been
added, a mean reduction in probing depth of 1.63mm (B)
and 1.93mm (L) was achieved six months postoperatively.
In the control sites, where BMPs were not used, a reduction
of 1.93mm (B) and  2.0mm (L) was obtained. In Table 3, it can
be noticed that the groups did not present statistically
significant differences between them regarding the reduction
in PPD at six months, even though it was significant in two
groups from the initial examination to the six-month analysis
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(Tables 4 and 5). The reduction in PPD according the ANOVA
method complemented by the Tukey test was statistically
significant (p<0.05) at 3-month postoperatively (Tables 4
and 5) in the test and control groups, although there was no
statistically significant difference between the results
obtained at three and sixth months.
When analyzing the gain of CAL, it is observed that, at
six months, the test sites presented a mean gain of 1.60 mm
(B) and 1.46 mm (L), while the control sites presented a
mean gain of 1.03 mm (B) and 1.30 mm (L). Those differences
were not statistically significant (Table 7). In the same way,
the analysis of variance showed that the attachment gain
was significant in both groups (p<0.05) at three months
postoperatively, maintaining the lack of significant difference
(p<0.05) at six months postoperatively (Tables 8 and 9).
Group     MI   3m   6m  Friedman (p)
    x                      dp           x                      dp           x                      dp
Test 0,766 0,359 0,616 0,471 0,660 0,645 0,266 ns
Control 0,823 0,503 0,618 0,494 0,777 0,723 0,377 ns
Wilcoxon (p) 0,892 ns 0,715 ns 0,398 ns
ns- Non-significant differences (P<0.05)
TABLE 1
Group     MI   3m   6m  Friedman (p)
    x                      dp           x                      dp           x                      dp
Test 1.829a 0.363 1.220b 0.581 1.017c 0.587 0.002*
Control 1.827a 0.341 1.208b 0.548 1.064b 0.573 0.004*
TABLE 2
* statistically significant difference  (P<0.05)
Same letters indicate non-significant differences
Variation Aspect   Test     Control   P
          x                      dp           x                      dp
3m-MI B -1.400 1.183 -2.000 1.647 0.178ns
L -1.533 1.125 -1.733 1.449 0.657ns
6m-MI B -1.633 1.141 -1.933 1.347 0.443ns
L -1.933 0.961 -2.000 1.511 0.886ns
6m-3m B -2.333 0.863 0.066 0.728 0.340ns




The gingival recession is a frequent finding after GTR.
Nevertheless, it has not been considered significant29. In
this study, the occurrence of a significant recession in the
control group compared to the test group did not yield
differences between the groups concerning the attachment
gain (Table 6).
The presence and quantity of new bone can only be
determined by means of studies that accomplished surgical
reentrance or microscopic analysis. The filling  of intrabony
defects by neoformed bone tissue has been verified during
a reentrance surgery done at the six months postoperatively
in some reports13. However, the nature of the neoformed
tissue and the occurrence of regeneration can just be defined
by microscopic analysis. In the present study, those
procedures were not applied for ethical reasons and were
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based on data from the literature for establishment of the
evaluation periods employed.
Many factors are well accepted as playing key roles in
regenerative procedures: initial depth of the defect, number
of walls of the bony defect4, careful daily plaque control,
adequate control of membrane infection, creation and
maintenance of space below the membrane, and smoking25,26.
The improper control of those factors can be responsible
PPD
Face gl QM Effect gl error QM error F P
Teste V 2 11,705 28 0,574 20 <0,001*
L 2 15,622 28 0,503 31,047 <0,001*
Controle V 2 19,355 28 0,843 22,942 <0,001*
L 2 17,688 28 0,772 22,906 <0,001*
* significant statistically difference (p<0,05)
TABLE4
Group Face  MI 3m 6m
     x     dp     x                            dp     x                           dp
V 5,466a 1,060 4,066b 0,883 3,833b 0,879
Test
L 5,733a 1,162 4,200b 1,424 3,800b 1,146
V 5,866a 1,597 3,866b 1,302 3,933b 0,979
Control
L 5,933a 1,449 4,200b 1,373 3,933b 0,883
TABLE 5
Same letter- No significant differences
Variation Face      Test Control   P
    x    dp     x    dp
3m-MI V 0,133 0,351 0,533 0,743 0,028*
L 0,200 0,560 0,466 0,743 0,262ns
6m-MI V 0,133 0,351 0,533 0,743 0,028*
L 0,200 0,560 0,466 0,743 0,262ns
6m-3m V 0 0 —
L 0 0 —
TABLE 6
* significant statistically difference (P<0,05); ns No significant differences
for the differences observed in the results of the studies
accomplished.
The level of plaque control performed by the patient has
an important influence in regenerative therapy. Better levels
of clinical attachment have been observed in patients with
better plaque control compared to the patients with poor
plaque control26.
All patients in this study were instructed on oral hygiene
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at the first appointment. The test and control groups were
standardized and, at initial measurement, a mean PI equal or
lower than 1 was obtained in the recording of the entire
mouth and specifically in the study sites.
Within the criteria of the methodology of this study,
smokers were not included in the sample since they are at a
higher risk of exposition of the barrier, have a low healing
response, and as a result show a smaller attachment gain
Variation Face      Test Control   P
    x    dp     x    dp
3m-MI V -1,200 1,014 -1,233 1,545 0,938ns
L -1,266 0,883 -0,833 1,175 0,201ns
6m-MI V -1,600 1,168 -1,033 1,245 0,165ns
L -1,466 0,972 -1,300 1,114 0,591ns
6m-3m V -0,400 0,890 0,200 0,840 0,091ns
L -0,200 0,959 -0,466 0,833 0,326ns
TABLE7
No significant differences (P<0,05)
PPD
Group Face gl QM Effect gl error QM error F P
                      V 2 10,40 28 0,530 19,587 <0,001*
Test
                      L 2 9,488 28 0,441 21,503 <0,001*
                      V 2 6,572 28 0,774 8,484 0,001*
Control
                      L 2 6,505 28 0,553 11,760 <0,001*
* significant statistically difference (p<0,05)
TABLE8
CAL
Face  MI 3m 6m
     x     dp     x                            dp     x                           dp
V 5,266a 1,099 4,066b 1,162 3,666b 1,331
L 5,400a 1,352 4,133b 1,164 3,933b 1,321
V 5,633a 1,099 4,400b 1,162 4,600b 1,331
L 5,700a 1,352 4,866b 1,164 4,400b 1,321
TABLE 9
Same letter- No significant differences
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and higher tendency to bone loss after regenerative
therapy25.
In addition, the pairs of defects selected always referred
to the same type of tooth (molars and premolars) and located
in the same jaw.
The HA carrier associated with the pool of BMPs in this
study may have partially interfered with the process of bone
formation by the BMPs, since it is present in solid particles.
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According to Kuboki et al.12, the geometrical structure of
hydroxyapatite in solid particles does not offer adequate
environment for vascularization, partially interfering with
the osteogenesis. On the other hand, in HA with porous or
coral structure, there is creation of sufficient environment
for vascularization.
The tetracycline and citric acid compound employed in
this study was developed by the Department of Biochemistry
of the Bauru Dental School-USP. Sant’Ana20, when treating
root fragments in damaged periodontium with this
compound, noticed a greater number of adhered cells, the
desobliteration of the dentinal tubuli and removal of the
smear layer, with achievement of a more regular and “clean”
cementum surface, without evidence of remnants of calcified
or uncalcified tissue.
The findings of this study suggest that addition of the
pool of bovine BMPs in HA carrier to the lyophilized
demineralized bone matrix does not result in improvement
of the clinical parameters.
On the other hand, the stability and gain of clinical
attachment and the reduction in probing depth observed
during the treatment effectively resulted in improvement of
the clinical conditions in patients treated in both groups,
eliminating or at least reducing the existing periodontal
pockets.
CONCLUSIONS
- The addition of a pool of bovine BMPs to the
demineralized lyophilized bovine bone matrix (MB) did not
present additional clinical benefits in the treatment of
intrabony defects;
- The stability, gains in clinical attachment and reduction
in probing depth actually yielded an improvement in the
clinical conditions for both groups.
RESUMO
Este estudo teve como objetivo avaliar a aplicação do
“pool” de BMPs bovinas no tratamento de defeitos intra-
ósseos. A amostra constou de quinze indivíduos com idade
entre 26 e 57 anos, apresentando um par de defeitos intra-
ósseos comparáveis, localizados no mesmo arco em dentes
do mesmo tipo (pré-molares ou molares) e com perda de
inserção (PI) ³5mm. Em cada indivíduo, o defeito teste foi
tratado com a associação “pool” de BMPs- carreador
Hidroxiapatita reabsorvível (BMPs-HA), matriz orgânica
bovina desmineralizada liofilizada (MO) e barreira de
colágeno bovino, enquanto os defeitos controle foram
tratados com MO-HA e barreira de colágeno. Na avaliação
clínica aos seis meses após a medida inicial, o grupo teste
apresentou variação de profundidade de sondagem (PS) de
-1,63mm ± 1,141 na vestibular (V) e -1,93mm ± 0,961 na lingual
(L) e variação do nível de inserção (NI) de -1,60mm ± 1,168
na V e -1,46mm ± 0,972 na L. O grupo controle apresentou
variação de PS de -1,93mm ± 1,347 (V) e -2,0mm ± 1,511 (L) e
variação de NI de -1,03mm ± 1,245 (V) e -1,30mm ± 1,114 (L).
A análise de variância indicou que a variação de PS e NI foi
significativa em ambos os grupos (p<0,05). Entretanto, de
acordo com o teste t não houve diferença significativa entre
os grupos quanto à variação PS e NI (p<0,05). Em conclusão,
a aplicação do “pool” de BMPs não oferece benefícios
adicionais ao tratamento de defeitos intra-ósseos.
UNITERMOS: Regeneração periodontal; Defeitos intra-
ósseos; Proteínas ósseas morfogenéticas.
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